| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +508K | 100% | $38.95 | +$19.8M |
| Sells | 0 | ||||
| Net | +4 | +508K | 100% | +$19.8M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| John W. Childs | Director | $200M | +$9.05M | +4.73% | Mar 4, 2025 |
| Vlad Coric | Chief Executive Officer, Director | $123M | +$6M | +5.14% | Jan 5, 2025 |
| Gregory Bailey | Director | $71.6M | +$3.73M | +5.5% | Sep 24, 2024 |
| Matthew Buten | Chief Financial Officer | $7.47M | Jan 5, 2025 | ||
| Kimberly Gentile | SVP, Clinical Operations | $3.78M | Jan 5, 2025 | ||
| George Clark | VP, Chief Accounting Officer | $2.63M | Jan 5, 2025 | ||
| Bruce Car | Chief Scientific Officer | $1.34M | +$1.01M | +299% | Jan 5, 2025 |
| Irina Antonijevic | Director | $106K | Apr 30, 2024 | ||
| Michael Thomas Heffernan | Director | Apr 30, 2024 | |||
| Julia P. Gregory | Director | Apr 30, 2024 | |||
| Kishan Mehta | Director | Apr 30, 2024 | |||
| Robert J. Hugin | Director | Apr 30, 2024 | |||
| Biohaven Pharmaceutical Holding Co Ltd. | 10%+ Owner | Oct 3, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|